|
Indian Pediatr 2015;52: 346 |
 |
Caffeine in a Term Neonate with Apnea
|
*Abdul Razak and N Karthik Nagesh
Neonatal Medicine, Motherhood Hospital,
Bangalore, Karnataka, India.
Email: * [email protected]
|
A term neonate with recurrent central apnea was evaluated at our
neonatal intensive care unit (NICU). This male neonate, weighing 3800 g,
was vigorous at birth following a caesarian delivery at 38 weeks of
gestation. He required continuous positive airway pressure (CPAP)
support initially for transient tachypnea but subsequently could not be
weaned off as he had recurrent apneas. There was no significant
antenatal history. The neonate had recurrent respiratory pauses of 10-40
seconds duration, associated with desaturation/bradycardia, majority
requiring stimulation. There was no identifiable cause for apnea in this
neonate despite extensive work-up (septic
work-up/biochemistry/echocardiography/CSF analysis/neuroimaging/EEG/gastroesophageal
reflux evaluation/upper airway study/ metabolic screening). The neonate
was then labelled as having primary/idiopathic apnea, and was started on
trial of caffeine therapy after discussion with parents. Caffeine
citrate (20mg/kg) was injected intravenously, followed by 10 mg/kg every
24 hourly. There was noticeable improvement in symptoms, and the neonate
was weaned off from CPAP support after 3 days; he was discharged at 3
weeks of postnatal life on oral caffeine. Post-discharge home monitoring
with pulse-oximeter recorded no apneas. Follow-up of the infant showed
lag in weight velocity which catched-up after stopping caffeine at four
month of age. Developmental milestones were appropriate for age.
Respiratory pauses of >20 seconds or if associated
with bradycardia and cyanosis are labelled as apneas [1]. Apnea is a
grave sign in term neonates and could result from sepsis, meningitis or
severe brainstem dysfunction in hypoxic neonates. A term neonate with
temporal lobe hemorrhage can also present with apneic seizures [2,3].
The neonate in our care was well looking with no features of
encephalopathy. Caffeine therapy is extensively used in preterm neonates
with apnea of prematurity [1]; however, use of this drug in term
neonates is not well known. Its use is described for post-extubation
management, and also for bronchiolitis related apnea [4]. We presume
that the neonate had primary/idiopathic central apnea requiring
intervention that gradually resolved over a period.
References
1. Jing Z, Fernando G, Dezhi M. Apnea of prematurity:
From cause to treatment. Eur J Pediatr. 2011;170:1097-105.
2. Jeffrey JT, Howard PG. Temporal lobe hemorrhage in
the full-term neonate presenting as apneic seizures. J Perinatol.
2004;24:726-9.
3. Sirsi D1, Nadiminti L, Packard MA, Engel M,
Solomon GE. Apneic seizures: A sign of temporal lobe hemorrhage in
full-term neonates. Pediatr Neurol. 2007;37:366-70.
4. Cesar K, Iolster T, White D, Latifi S. Caffeine as
treatment for bronchiolitis related apnoea. J Pediatr Child Health.
2012;48:619.
|
|
 |
|